BCL2L11 Antibody

• Catalog Number: orb1239259
• Category: Antibodies
• Description: BCL2L11 Antibody
• Species/Host: Rabbit
• Clonality: Polyclonal
• Tested applications: ELISA, IF, IHC-P, WB
• Reactivity: Human, Mouse, Rat
• Isotype: IgG
• Immunogen: Anti-BIM antibody (orb1239259) was raised against a peptide corresponding to 20 amino acids near the amino terminus of human BIM. The immunogen is located within the first 50 amino acids of BIM.
• Concentration: 1 mg/ml
• Dilution range: WB: 0.5 μg/mL; IHC-P: 20 μg/mL; IF: 20 μg/mL.Antibody validated: Western Blot in human, mouse and rat samples; Immunohistochemistry in human samples; Immunofluorescence in human samples. All other applications and species not yet tested.
• Form/Appearance: Liquid
• Conjugation: Unconjugated
• MW: Predicted: 22kDObserved: 22kD
• Target: BCL2L11
• UniProt ID: O43521
• NCBI: O43521
• Storage: Bim antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
• Buffer/Preservatives: Bim Antibody is supplied in PBS containing 0.02% sodium azide.
• Alternative names: Bim Antibody: BAM, BIM, BOD, Bcl-2-like protein 11
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Western Blot Validation in Human Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: BIM orb1239259, (0.5 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: BIM orb1239259, (0.5 µg/mL), BIM orb1239258, (5 µg/mL), beta-actin (1 µg/mL) and GAPDH (0.02 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Western Blot Validation in Human Tissue. Loading: 15 µg of lysates per lane. Antibodies: BIM orb1239259, (0.5 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: Human thymus, Lane 2: Human colon.

Western Blot Validation in HeLa Cells. Loading: 15 µg of lysate per lane. Antibodies: BIM orb1239259, (0.5 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. BIM orb1239259 can detect all three human isoforms, including EL, L and S isoforms.

Western Blot Validation in Rat Myeloma Cell line. Loading: 15 µg of rat myeloma YB2/0 cell lysate per lane. Antibodies: BIM orb1239259, (0.5 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Immunofluorescence Validation of BIM in K562 Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed K562 cells labeling Bim with orb1239259 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).

Immunohistochemistry Validation of BIM in Human Skin Cancer Cells. Immunohistochemical analysis of paraffin-embedded human spleen tissue using anti-BIM antibody (orb1239259) at 20 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Induced Expression Validation of BIM in Mouse Hippocampus (Tsuchiya et al., 2011). The induction of Bim protein was detected by immunohistochemical analysis of mice after i.h. injection of epoxomicin with anti-BIM antibodies. Sections from epoxomicin-treated animals exhibited cells staining positive for Bim expression within the NeuN-positive population of neurons in the CA1 of the ipsilateral side. In contrast, Bim-positive cells were absent within the NeuNpositiveCA1 neurons on the contralateral side.

KD Validation of BIM in 293 Cells (Han et al., 2010). Immunofluorescence analysis with anti-BIM antibodies was performed for BIM in 293 cells transfected with control siRNA or BIM siRNA. BIM expression was disrupted after BIM siRNA knockdown.

Regulated Expression Validation of BIM in U266 Cells (Chen et al., 2012). Immunoblot analysis was carried out to monitor protein expression of 3 isoforms (EL, L, and S) of Bim with anti-BIM antibodies. BIM expression was up-regulated by flavopiridol treatment, which was blocked by Cycloheximide in U266 cells.

WB KD Validation of BIM in 293 Cells (Han et al., 2010). Western blot analysis with anti-BIM antibodies was performed for BIM in 293 cells transfected with control siRNA or BIM siRNA. BIM expression was disrupted after BIM siRNA knockdown.

KD Validation of BIM in Human Cell Lines (Chen et al., 2009). Human leukemia (U937 and Jurkat) and myeloma (U266) cells were stably transfected with constructs encoding shBim or a scrambled sequence (shNC). Immunoblotting was preformed to monitor expression of Bim in these cells with anti-BIM antibodies. BIM expression was disrupted after shBIM knockdown.

Localization Validation of BIM in Mouse Macrophages (Ulett et al., 2005). Immunoblots of subcellular fractions enriched for mitochondria and cytosol were used to determine BIM protein levels with anti-BIM antibodies in J774A cells. BIM is exclusively expressed in mitochondria.